In contrast to the preious study, there was no increase in heart attack risk among patients receiing aprotinin, while the risk of stroke was 35 percent lower.

• 与先期的研究结果相反，该研究发现接受抑肽酶治疗的病人心脏病发作的风险并没有增加，而发生中风的风险降低了35%25。